• Nextleaf Solutions Ltd. (OILS) has increased the distribution of its CBD oil and Glacial Gold branded consumer products
  • The company is launching Glacial Gold in British Columbia and has received an initial order from the BC Liquor Distribution Branch
  • The company also recently received a reorder from its NASDAQ-listed partner for high-purity CBD distillate produced by Nexleaf Labs
  • Nextleaf is an innovative cannabis processor that owns one of the largest portfolios of U.S. patents for the extraction, distillation, and delivery of cannabinoids
  • Nextleaf Solutions Ltd. (OILS) is currently down 4.65 per cent, trading at $0.205 per share

Nextleaf Solutions Ltd. (OILS) has increased the distribution of its CBD oil and Glacial Gold branded consumer products.

The company is launching Glacial Gold in British Columbia with an initial order of ingestible oils and vape cartridges by the province’s Liquor Distribution Branch.

All Glacial Gold CBD products are made using biomass inputs from Nextleaf’s BC hemp supplier. The hemp biomass is distilled into CBD oils using Nextleaf’s patented extraction and purification technology.

“We’re proud to process hemp sourced from BC farms, fed by glacial waters of BC mountains, allowing Nextleaf to honor Glacial Gold’s legacy and keeping it a truly authentic BC brand from soil to oil,” said Nextleaf CEO Paul Pedersen.

The company also recently received a reorder from its NASDAQ-listed partner for high-purity CBD distillate produced by Nexleaf Labs.

The CBD distillate ingredients are used to power the partner’s products, which include edibles, ingestible oils, and vape cartridges sold across Canada.

Nextleaf is an innovative cannabis processor that owns one of the largest portfolios of U.S. patents for the extraction, distillation, and delivery of cannabinoids.

The company continues to advance its CBD product portfolio, which includes over 70 U.S. and global patents.

Nextleaf Solutions Ltd. (OILS) is currently down 4.65 per cent, trading at $0.205 per share as of 10:36 am ET.

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.